DNX Biopharmaceuticals is Drug Discovery in United States that focus on biopharmaceutical services business. Founded in 2014. They cover business area such as owner, operator, long-act therapeutic protein, patient, life-long disease, development, new therapeutic protein, biological drug, auto-inflammatory disease, medical researcher, treatment, rheumatoid arthritis.
2014
( 10 years old in 2024 )
Biopharmaceutical Services
-
19800 MacArthur Boulevard
Suite 300
Irvine, CA 92612
United States
Private
owneroperatorlong-act therapeutic proteinpatientlife-long diseasedevelopmentnew therapeutic proteinbiological drugauto-inflammatory diseasemedical researchertreatmentrheumatoid arthritis
* We use standard office opening hours in near DNX Biopharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
DNX Biopharmaceuticals is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), DNX Biopharmaceuticals business is focusing on Biopharmaceutical Services.
DNX Biopharmaceuticals headquarter office and corporate office address is located in 19800 MacArthur Boulevard Suite 300 Irvine, CA 92612 United States.
DNX Biopharmaceuticals was founded in United States.
In 2024, DNX Biopharmaceuticals is currently focus on biopharmaceutical services sector.
Above is snippet of Google Trends for "biopharmaceutical services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with DNX Biopharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
